Resultados de la búsqueda 321-330 of 12672 for Eosinophilia

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    Patients referred for an ascending aortic aneurysm that meets the inclusion criteria will be randomized to the early elective surgery group or the surveillance ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences. Hematology Electronic ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety, feasibility, and efficacy of vagus nerve stimulation (VNS) paired with mobility training to improve lower ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences. Fertility Outcomes in Lymphoma Patients.

  9. Hematología - Ensayos clínicos - Mayo Clinic

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...